FDA Clearance Tracker · P100047-S142
HeartWare HVAD System
Last checked: Nov 20, 2026Latest source record: May 7, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 7, 2020
Approved
Time to decision
307 days
Received Jul 5, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100047-S142
- Device name
- HeartWare HVAD System
- Applicant
- Medtronic
- Applicant location
- Mounds View, MN
- Received
- Jul 5, 2019
- Decided
- May 7, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100047
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the design modifications to the monitor AC adapter and labeling modifications to the HVAD Physician IFU and Patient Manual.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
K262572 · Decided Oct 29, 2026 · 94 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Lumbar (MAX) · Orthopedic Surgery
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.